179 related articles for article (PubMed ID: 16596744)
1. Commentary: where and how could biomarkers be used in 2016?
Finley Austin MJ; Babiss L
AAPS J; 2006; 8(1):E185-9. PubMed ID: 16596744
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine.
Jain KK
Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
[TBL] [Abstract][Full Text] [Related]
3. Assessing patient readiness for the clinical adoption of personalized medicine.
Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
[TBL] [Abstract][Full Text] [Related]
4. Personalized medicine: challenges in assessing and capturing value in the commercial environment.
Ferrara J
Expert Rev Mol Diagn; 2006 Mar; 6(2):129-31. PubMed ID: 16512770
[No Abstract] [Full Text] [Related]
5. Molecular diagnostics and personalized medicine. IBC Life Sciences Conference on Pharmacogenomics, June 24-25, 2003, London, UK.
Sanders R
Pharmacogenomics; 2003 Sep; 4(5):541-5. PubMed ID: 14518454
[No Abstract] [Full Text] [Related]
6. 2005 International Conference on Metabolic Profiling. November 14-15, 2006, NC, USA.
Chace DH
Expert Rev Mol Diagn; 2006 Mar; 6(2):135-6. PubMed ID: 16512772
[No Abstract] [Full Text] [Related]
7. Implications of pharmacogenomics for drug development and clinical practice.
Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics: the promise of personalized medicine.
Hood E
Environ Health Perspect; 2003 Aug; 111(11):A581-9. PubMed ID: 12928155
[No Abstract] [Full Text] [Related]
9. Personalized medicine: elusive dream or imminent reality?
Lesko LJ
Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
[TBL] [Abstract][Full Text] [Related]
10. The disruptive nature of personalized medicine technologies: implications for the health care system.
Carlson RJ
Public Health Genomics; 2009; 12(3):180-4. PubMed ID: 19204421
[TBL] [Abstract][Full Text] [Related]
11. The current status and future potential of personalized diagnostics: Streamlining a customized process.
Richmond TD
Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
[TBL] [Abstract][Full Text] [Related]
12. Personalized medicine prompts push to redesign clinical trials.
Singer E
Nat Med; 2005 May; 11(5):462. PubMed ID: 15875041
[No Abstract] [Full Text] [Related]
13. From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community.
Frueh FW; Gurwitz D
Pharmacogenomics; 2004 Jul; 5(5):571-9. PubMed ID: 15212593
[TBL] [Abstract][Full Text] [Related]
14. Role of nanobiotechnology in developing personalized medicine for cancer.
Jain KK
Technol Cancer Res Treat; 2005 Dec; 4(6):645-50. PubMed ID: 16292884
[TBL] [Abstract][Full Text] [Related]
15. The future of highly personalized health care.
Robson B; Garnier J
Stud Health Technol Inform; 2002; 80():163-74. PubMed ID: 12026125
[TBL] [Abstract][Full Text] [Related]
16. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
Walk EE
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
[TBL] [Abstract][Full Text] [Related]
17. The conundrum of personalized cancer management, drug development, and economics.
DeNardo GL
Cancer Biother Radiopharm; 2007 Dec; 22(6):719-21. PubMed ID: 18158762
[No Abstract] [Full Text] [Related]
18. Molecular imaging and personalized medicine: an uncertain future.
Nunn AD
Cancer Biother Radiopharm; 2007 Dec; 22(6):722-39. PubMed ID: 18158763
[TBL] [Abstract][Full Text] [Related]
19. Advances in pharmacogenomics technologies.
Bhasker CR; Hardiman G
Pharmacogenomics; 2010 Apr; 11(4):481-5. PubMed ID: 20350126
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine.
Vizirianakis IS
Eur J Pharm Sci; 2002 Apr; 15(3):243-50. PubMed ID: 11923056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
